Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 41

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 41
---
 mix toward lower-margin products and markets. Gross margin remained
strong overall, reflecting the Company’s continued focus on cost management and operational efficiency. 

Selling,
general and administrative expenses for 2025 and 2024 were as follows: 

    2025  
    2024  
    Change 
  
    Dental 
    $891,719  
    $883,666  
    $8,053 
  
    Medical 
     316,544  
     375,189  
     (58,645)
  
    Corporate 
     1,530,748  
     1,805,914  
     (275,166)
  
    Total selling, general and administrative expenses 
    $2,739,011  
    $3,064,769  
    $(325,758)

Consolidated selling, general, and administrative (SG&A) expenses for
the three months ended September 30, 2025, were approximately $2.7 million, compared to $3.1 million for the same period in 2024, representing
a decrease of approximately $325,000, or 10%. The reduction primarily reflects management’s continued focus on cost containment
and operational efficiency.

Employee salaries and benefits decreased by approximately $147,000 for
the three months ended September 30, 2025, compared to the same period in 2024, primarily due to workforce realignment and headcount optimization.
In addition, the Company achieved further savings of approximately $178,000 through reductions in marketing, consulting, professional
service fees, insurance, royalties, regulatory, travel, and other general administrative expenses.

These cost reduction measures are part of management’s ongoing initiatives
to streamline operations, align expenses with current revenue levels, and support the Company’s transition toward sustainable profitability

Research
and Development for 2025 and 2024 were as follows:

    2025  
    2024  
    Change 
  
    Dental 
    $15,401  
    $232,056  
    $(216,655)
  
    Medical 
     825  
     -  
     825 
  
    Corporate 
     -  
     -  
     - 
  
    Total research and development 
    $16,226  
    $232,056  
    $(215,830)

Consolidated research and development (R&D) expenses